Ram Ganapathi

4.9k total citations
132 papers, 4.0k citations indexed

About

Ram Ganapathi is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ram Ganapathi has authored 132 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Molecular Biology, 67 papers in Oncology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ram Ganapathi's work include Cancer therapeutics and mechanisms (56 papers), Cancer Treatment and Pharmacology (19 papers) and Lung Cancer Research Studies (17 papers). Ram Ganapathi is often cited by papers focused on Cancer therapeutics and mechanisms (56 papers), Cancer Treatment and Pharmacology (19 papers) and Lung Cancer Research Studies (17 papers). Ram Ganapathi collaborates with scholars based in United States, Germany and United Kingdom. Ram Ganapathi's co-authors include Dale Grabowski, Mahrukh K. Ganapathi, Awtar Krishan, Ronald M. Bukowski, S. A. Vaziri, Paul Elson, G. Thomas Budd, Tarek Mekhail, Brian I. Rini and Kenichi Chikamori and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Ram Ganapathi

132 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ram Ganapathi United States 33 2.7k 1.8k 734 705 298 132 4.0k
John P. Fruehauf United States 37 2.1k 0.8× 1.4k 0.8× 756 1.0× 567 0.8× 370 1.2× 100 4.2k
Norma O’Donovan Ireland 36 2.2k 0.8× 2.3k 1.3× 838 1.1× 637 0.9× 404 1.4× 116 4.3k
Robert J. Kinders United States 36 2.3k 0.9× 1.9k 1.1× 812 1.1× 484 0.7× 411 1.4× 129 4.0k
Monica R. Maiello Italy 23 2.4k 0.9× 2.2k 1.2× 775 1.1× 1.1k 1.6× 278 0.9× 40 4.4k
Jill Kolesar United States 37 2.0k 0.8× 1.8k 1.0× 620 0.8× 936 1.3× 368 1.2× 192 4.3k
Ralph E. Parchment United States 37 2.3k 0.9× 1.8k 1.0× 729 1.0× 430 0.6× 478 1.6× 184 4.4k
Deepak Sampath United States 37 2.9k 1.1× 1.9k 1.1× 845 1.2× 796 1.1× 540 1.8× 110 5.0k
Anne W. Hamburger United States 29 2.7k 1.0× 2.2k 1.2× 764 1.0× 555 0.8× 495 1.7× 110 4.9k
Carlo V. Catapano Switzerland 37 2.6k 1.0× 1.4k 0.8× 783 1.1× 550 0.8× 632 2.1× 116 4.4k
Gabriella Zupi Italy 45 3.9k 1.5× 1.9k 1.1× 973 1.3× 431 0.6× 559 1.9× 161 5.6k

Countries citing papers authored by Ram Ganapathi

Since Specialization
Citations

This map shows the geographic impact of Ram Ganapathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ram Ganapathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ram Ganapathi more than expected).

Fields of papers citing papers by Ram Ganapathi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ram Ganapathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ram Ganapathi. The network helps show where Ram Ganapathi may publish in the future.

Co-authorship network of co-authors of Ram Ganapathi

This figure shows the co-authorship network connecting the top 25 collaborators of Ram Ganapathi. A scholar is included among the top collaborators of Ram Ganapathi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ram Ganapathi. Ram Ganapathi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michelson, Andrew P., Shannon McDonough, Cheryl L. Willman, et al.. (2020). Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemia. Scientific Reports. 10(1). 5486–5486. 3 indexed citations
2.
Wienert, Stephan, Dan Cacsire Castillo‐Tong, Caroline Kreuzinger, et al.. (2018). Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer. Neoplasia. 20(3). 280–288. 20 indexed citations
3.
4.
Kozuki, Toshiyuki, Kenichi Chikamori, Marius Surleac, et al.. (2017). Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint. Nucleic Acids Research. 45(10). 5995–6010. 23 indexed citations
5.
Patel, Jai N., Jalid Sehouli, Kirsten M. Timms, et al.. (2016). Characteristics of homologous recombination deficiency (HRD) in paired primary and recurrent high-grade serous ovarian cancer (HGSOC). Annals of Oncology. 27. vi35–vi35. 3 indexed citations
6.
Gillet, Jean-Pierre, Anna Maria Calcagno, Sudhir Varma, et al.. (2012). Multidrug Resistance–Linked Gene Signature Predicts Overall Survival of Patients with Primary Ovarian Serous Carcinoma. Clinical Cancer Research. 18(11). 3197–3206. 40 indexed citations
7.
Chikamori, Kenichi, et al.. (2010). DNA Topoisomerase II Enzymes as Molecular Targets for Cancer Chemotherapy. Current Cancer Drug Targets. 10(7). 758–771. 79 indexed citations
8.
George, Saby, Robert Dreicer, Tong Shen, et al.. (2008). Phase I/II Trial of 5-Fluorouracil and a Noncytotoxic Dose Level of Suramin in Patients with Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer. 6(2). 79–85. 10 indexed citations
9.
Choueiri, Toni K., Tarek Mekhail, Thomas E. Hutson, et al.. (2006). Phase I trial of phenoxodiol delivered by continuous intravenous infusion in patients with solid cancer. Annals of Oncology. 17(5). 860–865. 34 indexed citations
10.
Chikamori, Kenichi, Jason E. Hill, Dale Grabowski, et al.. (2006). Downregulation of topoisomerase IIβ in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest. Leukemia. 20(10). 1809–1818. 25 indexed citations
11.
Rojas‐Espaillat, Luis, Denise Uyar, Dale Grabowski, et al.. (2005). Apoptotic pathways induced by ixabepilone in paclitaxel-refractory ovarian carcinoma cells. Cancer Research. 65. 1257–1257. 8 indexed citations
12.
Chikamori, Kenichi, Dale Grabowski, Michael Kinter, et al.. (2003). Phosphorylation of Serine 1106 in the Catalytic Domain of Topoisomerase IIα Regulates Enzymatic Activity and Drug Sensitivity. Journal of Biological Chemistry. 278(15). 12696–12702. 53 indexed citations
13.
14.
Zhou, Zhichao, Leonard A. Zwelling, Ram Ganapathi, & Eugenie Kleinerman. (2001). Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase II α gene transfer is independent of topoisomerase II β. British Journal of Cancer. 85(5). 747–751. 11 indexed citations
15.
Ganapathi, Mahrukh K., Ronald M. Bukowski, Ram Ganapathi, et al.. (1996). Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.. PubMed. 7(7). 923–9. 17 indexed citations
16.
Peereboom, D., Ram Ganapathi, Olaf van Tellingen, et al.. (1996). Phase I trial of vinblastine plus phenytoin Pharmacokinetic analysis. 37. 182. 1 indexed citations
17.
Budd, G. Thomas, Ram Ganapathi, L. Bauer, et al.. (1993). Phase I study of WR-2721 and carboplatin. European Journal of Cancer. 29(8). 1122–1127. 23 indexed citations
18.
19.
Miller, Robin Lin, Ronald M. Bukowski, G. Thomas Budd, et al.. (1988). Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial.. Journal of Clinical Oncology. 6(5). 880–888. 112 indexed citations
20.
Krishan, Awtar, Ram Ganapathi, & Mervyn Israel. (1978). Effect of adriamycin and analogs on the nuclear fluorescence of propidium iodide-stained cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(11 Pt 1). 3656–62. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John P. Fruehauf Breakdown of academic impact, for papers by Norma O’Donovan Breakdown of academic impact, for papers by Robert J. Kinders Breakdown of academic impact, for papers by Monica R. Maiello Breakdown of academic impact, for papers by Jill Kolesar Breakdown of academic impact, for papers by Ralph E. Parchment Breakdown of academic impact, for papers by Deepak Sampath Breakdown of academic impact, for papers by Anne W. Hamburger Breakdown of academic impact, for papers by Carlo V. Catapano Breakdown of academic impact, for papers by Gabriella Zupi
Rankless by CCL
2026